A proton centre is among the most capital-intensive projects in cancer care, which makes the Assam proton therapy centre an infrastructure story as much as a clinical one. Assam has approved ₹600 crore for a proton beam therapy unit at Guwahati Medical College and Hospital (GMCH), made up of a ₹315 crore World Bank loan for equipment and ₹285 crore from the state, according to press reports, and expects at least three years before it opens. This analysis looks at the financing structure, the utilisation challenge, the equipment market and the risks, using our own labelled calculations. It offers no investment recommendation.
Assam proton therapy centre: business takeaways
- Total approved cost is ₹600 crore: about 52.5% from a World Bank loan and 47.5% from the state, by our own calculation.
- The cost covers equipment, specialised infrastructure including a bunker, and long-term operation and maintenance support, with five years of comprehensive maintenance.
- Operations are at least three years away; training takes one to one and a half years.
- The equipment vendor, capacity and charges were not disclosed.
- The Chief Minister says it will be India’s first public-sector proton centre; two private hospitals reportedly already offer the therapy. We could not independently verify these claims.
Financing structure of the Assam proton therapy centre
Using a multilateral loan for the equipment and state funds for the rest is a common structure for public projects. A loan from the World Bank typically comes with procurement rules, which usually mean an open tender and documented evaluation, though the reports do not describe the process. By our own calculation, the ₹285 crore state share is about 47.5% of the total, which is a substantial fiscal commitment for a state. Earlier reports cited ₹500 crore and ₹550 crore, so the approved sum is higher than previous estimates. The rise suggests that scope grew, for example to include operation and maintenance support, or that cost estimates were refined, but the sources do not say which.
Utilisation: the key economic question for the Assam proton therapy centre
Proton facilities have high fixed costs, so the number of patients treated each year determines whether they are financially sustainable. The sources give no capacity, patient volume or tariff. A centre in a public hospital may set charges below private rates or subsidise some patients, which lowers revenue per patient but supports access. The north-east has a large catchment, and the Chief Minister said patients from elsewhere could also be treated, but without volume projections it is impossible to estimate payback. We make no such estimate.
Utilisation also depends on referral pathways. Proton therapy suits a minority of cancer cases, so oncologists across the region would need to know when to refer, and tumour boards would need clear selection criteria. Without that, an expensive machine can sit underused even when demand exists in principle.
The equipment market and the Assam proton therapy centre
A small number of global manufacturers supply proton systems, and the sources do not name the supplier for this project. Choices include large multi-room installations and compact single-room systems. Acumen Research and Consulting’s report notes that multi-room systems are expected to grow significantly. We have also published an analysis of this market in our proton therapy market report. The tender outcome will signal which model the state prefers.
Execution risks for the Assam proton therapy centre
Risks include construction of a shielded vault, installation and commissioning, hiring and training of physicists, radiation oncologists and technicians, and regulatory licensing by the Atomic Energy Regulatory Board. Currency movements may affect the cost of imported equipment financed in foreign currency, though the sources do not say how the loan is denominated. Reports note that the training period of one to one and a half years must overlap with construction to meet the timeline.
Scenarios for the Assam proton therapy centre
- On schedule: tender, construction and training run in parallel and the centre opens within about three years, as reported.
- Delayed: tender or construction slips, pushing the opening later and raising costs, which the state would need to absorb.
- Underused: the machine opens but referrals and affordability limit patient numbers, reducing the public-health return.
These are illustrative scenarios from us and not forecasts. The sources give no probabilities.
Market context from Acumen Research and Consulting
Acumen Research and Consulting’s Proton Therapy Market report values the global market at USD 516 million in 2022 and projects USD 2,448 million by 2032, a CAGR of 17% for 2023 to 2032, with North America above 42% and Asia Pacific growing about 18.1% a year. The accelerator segment held more than 50% of 2022 revenue. By our own calculation, the forecast is about 4.7 times the 2022 value. The page was last updated in May 2023 and its title misstates the 2032 figure, so use the numbers as indicative.
Questions policymakers and analysts may ask about the Assam proton therapy centre
How many patients per year is the centre designed for? What will it charge, and will insurance schemes cover it? Which vendor will be chosen and under what contract terms? How will the state staff it? What happens if the timeline slips? None of these is answered in the sources, and this article offers no investment view. See our industry insights.
Timeline of the Assam proton therapy centre
- 2025: initial announcement of a proton centre at a state cancer institution.
- Mid-2026: reports cite about ₹550 crore.
- Late August 2026: ₹600 crore approval reported.
- At least three years later: operations expected.
General background: why public proton centres are rare
Proton systems cost far more than conventional radiotherapy machines and need specialised teams, so most centres worldwide are in private or academic settings. Public programmes often rely on development finance and phased roll-outs. The National Cancer Institute explains that proton therapy delivers radiation with less dose beyond the tumour, which is why it is considered for some tumours near critical organs and for children, though it is not necessary for every patient.
Our analysis of the Assam proton therapy centre
In our assessment, the Assam proton therapy centre is a bold public-sector bet whose success will be decided by utilisation, access rules and execution. The funding is in place but the operating model is not yet visible.
What is not disclosed about the Assam proton therapy centre
- Vendor, number of rooms and annual patient capacity.
- Treatment pricing and insurance coverage.
- Loan terms and repayment arrangements.
Risks and caveats
This article relies on press reports of statements by the Chief Minister and not on an official order. Our calculations are labelled. It is news reporting and not investment or medical advice.
What to watch next
- Tender and vendor selection.
- Construction milestones.
- Access and pricing policy.
FAQ
What is the total cost?
About ₹600 crore, according to press reports.
Who funds it?
A ₹315 crore World Bank loan and ₹285 crore from the state.
When will it open?
At least three years from approval.
How we reported this: we relied on press reports of the Assam government’s announcement, public pages from the World Bank, the National Cancer Institute and India’s atomic energy regulator, and the Acumen Research and Consulting report cited above. Our calculations are labelled. Last updated 2 November 2026. This is news reporting and not advice.
